Once upon a time Intel was a technology darling, that sadly was many moons ago as it got left behind with its rooted in the past attitude. Today it reported the fifth consecutive quarter of falling sales and the second consecutive quarter of losses. Intel reported first-quarter results on Thursday with a 133% annual reduction in earnings per share. This led to the biggest loss in the company’s history. Sadly, the terrible earnings were anticipated and even less than expected, … Continue reading “Intel Largest Quarterly Loss Ever as Revenue Collapsed 36% Over The Year, But There is Hope”
AMD Warns on PC Slump but Gains on Intel in Lucrative Data Center Market
Advanced Micro Devices reported Tuesday quarterly revenue ahead of consensus, AMD however guided lower for the quarter ahead by over $150 million. Analysts and investors were excited that AMD is gaining further ground on Intel. The stock traded higher on AMD making up for a personal-computer slump with gains in the lucrative data center market. The company’s data center business revenue grew 42% in the quarter, compared with the 33% decline recorded at INTC’s data center and artificial intelligence unit … Continue reading “AMD Warns on PC Slump but Gains on Intel in Lucrative Data Center Market”
Texas Instruments Automotive Chips Strength Balances Weak Industrial Demand
Texas Instruments, the largest manufacturer of analog and embedded processors in America, reported better than expected fourth quarter results and also provided Q1 guidance that met analyst estimates but at the same time demand remains under pressure with customers working to reduce their inventory levels. The softer weaker quarter-over-quarter growth reflecting slowing demand spreading from personal electronics which was 24% of IT’s 2021 revenue to a more significant industrial markets which had 41% of revenue. The automotive industry continues to … Continue reading “Texas Instruments Automotive Chips Strength Balances Weak Industrial Demand”
US Weekly IPO and SPAC Monitor: Following Mobileye’s Strong Debut Watch for Refreshed Filings
Following the strong debut of the Intel Mobileye IPO there are no confirmed IPOs scheduled for the week ahead but some shuffling of papers for a number of micro-caps on the calendar looking to price on a “day-to-day” basis. Often run ups in the stock market as we have seen in the past week bring a few out as brokers look to shift deals in the pipeline to investors. A feature of the IPO market this year is the many … Continue reading “US Weekly IPO and SPAC Monitor: Following Mobileye’s Strong Debut Watch for Refreshed Filings”
Intel Earnings Beat Lowered Expectations and Announces $10 billion in Cost Cuts
Semiconductor giant Intel stock plunged after another dismal earnings report and guidance cut. INTC reported adjusted second-quarter earnings of 29 cents a share, compared with $1.36 a share from a year ago. Intel is the 2nd heaviest weight in the SMH ETF and had been bid up prior to the report after the passing of the CHIPS and Science Act aimed at boosting US chip production. The offers more than $52 billion for US chipmakers as well as tax credits for domestic … Continue reading “Intel Earnings Beat Lowered Expectations and Announces $10 billion in Cost Cuts”
Self-Driving Tech Mobileye Gained 38 percent on Debut Valuing the IPO at $23 billion
Mobileye Global, Intel’s self-driving vehicle technology business shares debuted on the Nasdaq Wednesday and opened trading at $26.71, closing up 38 percent to $28.97, giving the company a market value of about $23 billion. MBLY raised $861 million by offering 41 million shares at $21, above the range of $18 to $20. INTC only floating 5% of its basic shares outstanding, well below the typical 15%, in light of current market conditions and market reaction. It listed on the Nasdaq … Continue reading “Self-Driving Tech Mobileye Gained 38 percent on Debut Valuing the IPO at $23 billion”
Intel Autonomous Driving Unit Mobileye $861 million IPO Prices Above Range
Mobileye Global, Intel’s self-driving vehicle technology business raised $861 million by offering 41 million shares at $21, above the range of $18 to $20. The IPO terms were announced last Tuesday and priced last night, a week later. INTC was sold off briskly on the news as the number was far below expectations of the $30 billion figure Intel had flouted about a month ago. The company is only floating 5% of its basic shares outstanding, well below the typical … Continue reading “Intel Autonomous Driving Unit Mobileye $861 million IPO Prices Above Range”
Texas Instruments Lowers Guidance on Retailers Bloated Inventories
Texas Instruments, the largest manufacturer of analog and embedded processors in America, traded over 5% lower despite reporting better than expected third quarter results beating by $0.06, and on revenues. TXN offered a weak outlook for the fourth quarter, guiding Q4 EPS below consensus and revenues below consensus. The softer weaker quarter-over-quarter growth reflects the slowing demand spreading from personal electronics which was 24% of IT’s 2021 revenue to a more significant industrial markets which had 41% of revenue. Texas … Continue reading “Texas Instruments Lowers Guidance on Retailers Bloated Inventories”
US Weekly IPO and SPAC Monitor: Intel’s Mobileye, Biotech’s ASP Isotopes and Intensity Therapeutics
A feature of the IPO market this year is the many names coming up for pricing and being delayed. No surprise with 87% issued in the last year down according to Dealogic. We have the Intel Mobileye IPO listing this week. MBLY is only floating 5% of its basic shares outstanding, well below the typical 15% after the market took to INTC last week. Two holdovers are also expected to debut in the week ahead. Isotope enrichment company ASP Isotopes … Continue reading “US Weekly IPO and SPAC Monitor: Intel’s Mobileye, Biotech’s ASP Isotopes and Intensity Therapeutics”
US Weekly IPO and SPAC Monitor: Gene editing Biotech Prime Medicine and Molybdenum Enricher Aerodynamic Separation Process
We are seeing a little activity in IPO land. A few deals are scheduled to price in the week ahead, and many still on the back burner. Gene editing biotech Prime Medicine (PRME) would be the first sizable IPO of the fourth quarter. Aerodynamic Separation Process (ASP) focusing on the commercialization of enriched Molybdenum-100 plans to list. Three holdovers from the past week are scheduled to price; Beamr Imaging (BMR), Intensity Therapeutics (INTS) and Alopexx (ALPX). Intel’s Mobileye (MBLY) will … Continue reading “US Weekly IPO and SPAC Monitor: Gene editing Biotech Prime Medicine and Molybdenum Enricher Aerodynamic Separation Process”